Cleo Diagnostics Ltd Health Care
Cancer Healthcare Medical

$TBC

High $0.36	Low $0.35	Trades -	Turnover $0	Volume 115,093
24 July 2026 at 8:10pm

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Stock Information

Code COV	Name Cleo Diagnostics Ltd	Country AU	Currency AUD
GIC Sector Health Care	GIC Group Health Care Equipment & Services	GIC Industry Health Care Equipment & Supplies	GIC Sub Industry Health Care Equipment
Sector Healthcare	IPO Date N/A	Fiscal Year June	Type Common Stock
Shares Outstanding 136,862,085	Shares Floated 83,251,838	Held by Insiders 39.055%	Held by Institutions 0%

Directors & Officers

Name & Education	Position
Dr. Richard Allman Ph.D.	MD, CEO & Executive Director
Dr. Andrew N. Stephens	Chief Scientific Officer & Executive Director
Prof. Thomas William Jobling	Lead Medical Advisor & Independent Non-Executive Director
Mr. Nathan Hodgson	Head of Operations
Ms. Dayna Louca	Head of Corporate Development
Ms. Pauline M. Moffatt AAICD, B.Com., FGIA	Company Secretary

COV Historic Dividends

Date	Amount
We found no dividends on record for COV.

End of Day Prices

Date	Close	Volume	Change
23-Jul	$0.35	173,740	-0.01 (1.41%)
22-Jul	$0.36	115,093	+0.01 (2.90%)
21-Jul	$0.35	41,906	-0.01 (2.82%)
20-Jul	$0.36	329,743	-0.01 (1.39%)
17-Jul	$0.36	1,432,227	-0.06 (14.29%)
18-Sep	$0.42	120,578	+0.05 (12.00%)
12-Sep	$0.38	150,494	-0.02 (3.85%)
11-Sep	$0.39	131,210	+0.03 (8.33%)
05-Sep	$0.36	283,224	+0.01 (2.86%)
04-Sep	$0.35	180,896	+0.01 (1.45%)
03-Sep	$0.35	105,109	-0.02 (5.48%)
29-Aug	$0.37	437,102	+0.03 (8.96%)
28-Aug	$0.34	45,354	-0.01 (2.90%)
22-Aug	$0.35	52,954	-0.02 (4.17%)
21-Aug	$0.36	44,784	+0.01 (2.86%)
7 up, 8 down, and 0 flat days

Market Cap (23-Jul) $47,303,668	EBITDA -	PE 0.00	Book Value $0.06
Dividend per Share N/A	Dividend Yield N/A	EPS $-0.03	Profit Margin N/A
Operating Margin -105.8%	ROA 27.12%	ROE 49.57%	Revenue (FY) $2,562,322
Revenue per Share $0.02	Gross Profit (FY) $2,562,322	Q' YOY Revenue Growth 373.4%	Q' YOY Earnings Growth -

Cleo Diagnostics Ltd Health Care
Cancer Healthcare Medical

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

COV Historic Dividends

Followers

Prices

Announcements

End of Day Prices

COV Cleo Diagnostics Ltd Health Care Cancer Healthcare Medical

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

COV Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Cleo Diagnostics Ltd Health Care
Cancer Healthcare Medical